99 related articles for article (PubMed ID: 12023017)
21. Negative regulation of CD95 ligand gene expression by vitamin D3 in T lymphocytes.
Cippitelli M; Fionda C; Di Bona D; Di Rosa F; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2002 Feb; 168(3):1154-66. PubMed ID: 11801650
[TBL] [Abstract][Full Text] [Related]
22. CD95 ligand (CD95L) in normal human lymphoid tissues: a subset of plasma cells are prominent producers of CD95L.
Sträter J; Mariani SM; Walczak H; Rücker FG; Leithäuser F; Krammer PH; Möller P
Am J Pathol; 1999 Jan; 154(1):193-201. PubMed ID: 9916933
[TBL] [Abstract][Full Text] [Related]
23. GRID: a novel Grb-2-related adapter protein that interacts with the activated T cell costimulatory receptor CD28.
Ellis JH; Ashman C; Burden MN; Kilpatrick KE; Morse MA; Hamblin PA
J Immunol; 2000 Jun; 164(11):5805-14. PubMed ID: 10820259
[TBL] [Abstract][Full Text] [Related]
24. Identification of SH3 domain interaction partners of human FasL (CD178) by phage display screening.
Voss M; Lettau M; Janssen O
BMC Immunol; 2009 Oct; 10():53. PubMed ID: 19807924
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage.
Mariani SM; Krammer PH
Eur J Immunol; 1998 Mar; 28(3):973-82. PubMed ID: 9541592
[TBL] [Abstract][Full Text] [Related]
26. Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid rafts.
Lang I; Fick A; Schäfer V; Giner T; Siegmund D; Wajant H
J Biol Chem; 2012 Jul; 287(28):24026-42. PubMed ID: 22645131
[TBL] [Abstract][Full Text] [Related]
27. Sunlight-induced basal cell carcinoma tumor cells and ultraviolet-B-irradiated psoriatic plaques express Fas ligand (CD95L).
Gutierrez-Steil C; Wrone-Smith T; Sun X; Krueger JG; Coven T; Nickoloff BJ
J Clin Invest; 1998 Jan; 101(1):33-9. PubMed ID: 9421463
[TBL] [Abstract][Full Text] [Related]
28. An unexpected role for FosB in activation-induced cell death of T cells.
Baumann S; Hess J; Eichhorst ST; Krueger A; Angel P; Krammer PH; Kirchhoff S
Oncogene; 2003 Mar; 22(9):1333-9. PubMed ID: 12618758
[TBL] [Abstract][Full Text] [Related]
29. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
Li S; Couvillon AD; Brasher BB; Van Etten RA
EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
[TBL] [Abstract][Full Text] [Related]
30. The three-dimensional solution structure and dynamic properties of the human FADD death domain.
Berglund H; Olerenshaw D; Sankar A; Federwisch M; McDonald NQ; Driscoll PC
J Mol Biol; 2000 Sep; 302(1):171-88. PubMed ID: 10964568
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
[TBL] [Abstract][Full Text] [Related]
32. The adaptor protein Gads (Grb2-related adaptor downstream of Shc) is implicated in coupling hemopoietic progenitor kinase-1 to the activated TCR.
Liu SK; Smith CA; Arnold R; Kiefer F; McGlade CJ
J Immunol; 2000 Aug; 165(3):1417-26. PubMed ID: 10903746
[TBL] [Abstract][Full Text] [Related]
33. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
[TBL] [Abstract][Full Text] [Related]
34. Erk-dependent cytosolic phospholipase A2 activity is induced by CD95 ligand cross-linking in the mouse derived Sertoli cell line TM4 and is required to trigger apoptosis in CD95 bearing cells.
Ulisse S; Cinque B; Silvano G; Rucci N; Biordi L; Cifone MG; D'Armiento M
Cell Death Differ; 2000 Oct; 7(10):916-24. PubMed ID: 11279537
[TBL] [Abstract][Full Text] [Related]
35. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of activation-induced cell death in individual human T cell clones.
Janssen O; Stocker A; Sanzenbacher R; Oberg HH; Siddiqi MA; Kabelitz D
Int Arch Allergy Immunol; 2000 Mar; 121(3):183-93. PubMed ID: 10729776
[TBL] [Abstract][Full Text] [Related]
37. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
38. Fluorescence resonance energy transfer analysis of proapoptotic CD95-EGF receptor interactions in Huh7 cells.
Eberle A; Reinehr R; Becker S; Häussinger D
Hepatology; 2005 Feb; 41(2):315-26. PubMed ID: 15660394
[TBL] [Abstract][Full Text] [Related]
39. Identification of Grb2 as a novel binding partner of the signaling lymphocytic activation molecule-associated protein binding receptor CD229.
Martín M; Del Valle JM; Saborit I; Engel P
J Immunol; 2005 May; 174(10):5977-86. PubMed ID: 15879090
[TBL] [Abstract][Full Text] [Related]
40. Directed discovery of bivalent peptide ligands to an SH3 domain.
Ferguson MR; Fan X; Mukherjee M; Luo J; Khan R; Ferreon JC; Hilser VJ; Shope RE; Fox RO
Protein Sci; 2004 Mar; 13(3):626-32. PubMed ID: 14978303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
